Provided by Tiger Trade Technology Pte. Ltd.

ContextLogic Holdings Inc.

7.70
0.0000
Post-market: 7.700.00000.00%16:01 EST
Volume:277.78K
Turnover:2.14M
Market Cap:205.75M
PE:-9.56
High:7.80
Open:7.63
Low:7.55
Close:7.70
52wk High:9.34
52wk Low:6.15
Shares:26.72M
Float Shares:26.24M
Volume Ratio:0.53
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8053
EPS(LYR):-1.2364
ROE:-6.47%
ROA:-6.65%
PB:1.46
PE(LYR):-6.23

Loading ...

Company Profile

Company Name:
ContextLogic Holdings Inc.
Exchange:
OTCQB
Establishment Date:
2010
Employees:
8
Office Location:
2648 International Blvd.,Ste 115,Oakland,California,United States
Zip Code:
94601
Fax:
- -
Introduction:
LogicBio Therapeutics, Inc., a genome editing company, focuses on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The GeneRide technology is designed to integrate corrective genes into a patient's genome to provide a therapeutic effect. The company's lead product candidate is LB-001 that is in Phase I/II clinical trials for the treatment of methylmalonic acidemia. It has a collaboration with Children's Medical Research Institute to develop next-generation capsids for gene therapy and gene editing applications in the liver, as well as two additional tissues; and a collaboration agreement with Takeda Pharmaceutical Company Limited to develop next-generation capsids for gene therapy and editing candidate LB-301 for the treatment of crigler-najjar syndrome. The company also has a strategic collaboration and option agreement with CANbridge Pharmaceuticals Inc. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts.